Status: open
CVS (lidocaine false advertising)
Defendant: CVS
Pharmacy retailer CVS agreed to pay $3.8 million to settle a case alleging that the retailer misrepresented its lidocaine products as delivering “maximum strength” relief, and its lidocaine patches as being able to adhere to skin for 8-12 hours. You may be eligible for a payment if you purchased qualifying CVS-branded lidocaine patches, creams, spray and roll-on products labeled “maximum strength” between Dec. 11, 2017, and July 18, 2023.